Literature DB >> 10631140

NF1 microdeletion syndrome: refined FISH characterization of sporadic and familial deletions with locus-specific probes.

P Riva1, L Corrado, F Natacci, P Castorina, B L Wu, G H Schneider, M Clementi, R Tenconi, B R Korf, L Larizza.   

Abstract

Two familial and seven sporadic patients with neurofibromatosis 1-who showed dysmorphism, learning disabilities/mental retardation, and additional signs and carried deletions of the NF1 gene-were investigated by use of a two-step FISH approach to characterize the deletions. With FISH of YAC clones belonging to a 7-Mb 17q11.2 contig, we estimated the extension of all of the deletions and identified the genomic regions harboring the breakpoints. Mosaicism accounted for the mild phenotype in two patients. In subsequent FISH experiments, performed with locus-specific probes generated from the same YACs by means of a novel procedure, we identified the smallest region of overlapping (SRO), mapped the deletion breakpoints, and identified the genes that map to each deletion interval. From centromere to telomere, the approximately 0.8-Mb SRO includes sequence-tagged site 64381, the SUPT6H gene (encoding a transcription factor involved in chromatin structure), and NF1. Extending telomerically from the SRO, two additional genes-BLMH, encoding a hydrolase involved in bleomycin resistance, and ACCN1, encoding an amiloride-sensitive cation channel expressed in the CNS-were located in the deleted intervals of seven and three patients, respectively. An apparently common centromeric deletion breakpoint was shared by all of the patients, whereas a different telomeric breakpoint defined a deletion interval of 0.8-3 Mb. There was no apparent correlation between the extent of the deletion and the phenotype. This characterization of gross NF1 deletions provides the premise for addressing correctly any genotype-phenotype correlation in the subset of patients with NF1 deletions.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10631140      PMCID: PMC1288315          DOI: 10.1086/302709

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  27 in total

1.  A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations.

Authors:  R M Cawthon; R Weiss; G F Xu; D Viskochil; M Culver; J Stevens; M Robertson; D Dunn; R Gesteland; P O'Connell
Journal:  Cell       Date:  1990-07-13       Impact factor: 41.582

2.  A YAC contig map of the human genome.

Authors:  I M Chumakov; P Rigault; I Le Gall; C Bellanné-Chantelot; A Billault; S Guillou; P Soularue; G Guasconi; E Poullier; I Gros
Journal:  Nature       Date:  1995-09-28       Impact factor: 49.962

3.  YAC mapping by FISH using Alu-PCR-generated probes.

Authors:  M Breen; B Arveiler; I Murray; J R Gosden; D J Porteous
Journal:  Genomics       Date:  1992-07       Impact factor: 5.736

4.  On the distribution of frequencies of mutation to genes determining harmful traits in man.

Authors:  A C Stevenson; C B Kerr
Journal:  Mutat Res       Date:  1967 May-Jun       Impact factor: 2.433

5.  Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus.

Authors:  D Viskochil; A M Buchberg; G Xu; R M Cawthon; J Stevens; R K Wolff; M Culver; J C Carey; N G Copeland; N A Jenkins
Journal:  Cell       Date:  1990-07-13       Impact factor: 41.582

6.  Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients.

Authors:  M R Wallace; D A Marchuk; L B Andersen; R Letcher; H M Odeh; A M Saulino; J W Fountain; A Brereton; J Nicholson; A L Mitchell
Journal:  Science       Date:  1990-07-13       Impact factor: 47.728

7.  The detection of contiguous gene deletions at the neurofibromatosis 1 locus with fluorescence in situ hybridization.

Authors:  K A Leppig; D Viskochil; S Neil; A Rubenstein; V P Johnson; X L Zhu; A R Brothman; K Stephens
Journal:  Cytogenet Cell Genet       Date:  1996

8.  Deletions spanning the neurofibromatosis 1 gene: identification and phenotype of five patients.

Authors:  L M Kayes; W Burke; V M Riccardi; R Bennett; P Ehrlich; A Rubenstein; K Stephens
Journal:  Am J Hum Genet       Date:  1994-03       Impact factor: 11.025

9.  Genomic organization of the neurofibromatosis 1 gene (NF1).

Authors:  Y Li; P O'Connell; H H Breidenbach; R Cawthon; J Stevens; G Xu; S Neil; M Robertson; R White; D Viskochil
Journal:  Genomics       Date:  1995-01-01       Impact factor: 5.736

10.  Mapping of human WHN gene in a 17q11.2 YAC contig and identification of an intragenic STR.

Authors:  L Corrado; P Colapietro; L Larizza; P Riva
Journal:  Mol Cell Probes       Date:  1999-06       Impact factor: 2.365

View more
  31 in total

1.  Identification of an atypical microdeletion generating the RNF135-SUZ12 chimeric gene and causing a position effect in an NF1 patient with overgrowth.

Authors:  Luca Ferrari; Giulietta Scuvera; Arianna Tucci; Donatella Bianchessi; Francesco Rusconi; Francesca Menni; Elena Battaglioli; Donatella Milani; Paola Riva
Journal:  Hum Genet       Date:  2017-08-03       Impact factor: 4.132

2.  17q24.2 microdeletions: a new syndromal entity with intellectual disability, truncal obesity, mood swings and hallucinations.

Authors:  Sarah Vergult; Andrew Dauber; Barbara Delle Chiaie; Elke Van Oudenhove; Marleen Simon; Ali Rihani; Bart Loeys; Joel Hirschhorn; Jean Pfotenhauer; John A Phillips; Shehla Mohammed; Caroline Ogilvie; John Crolla; Geert Mortier; Björn Menten
Journal:  Eur J Hum Genet       Date:  2011-12-14       Impact factor: 4.246

3.  Evidence for non-homologous end joining and non-allelic homologous recombination in atypical NF1 microdeletions.

Authors:  Marco Venturin; Cristina Gervasini; Francesca Orzan; Angela Bentivegna; Lucia Corrado; Patrizia Colapietro; Alessandra Friso; Romano Tenconi; Meena Upadhyaya; Lidia Larizza; Paola Riva
Journal:  Hum Genet       Date:  2004-04-21       Impact factor: 4.132

4.  Overexpression of Jazf1 induces cardiac malformation through the upregulation of pro-apoptotic genes in mice.

Authors:  Ki Beom Bae; Myoung Ok Kim; Dong Hoon Yu; Mi Jung Shin; Hei Jung Kim; Hyung Soo Yuh; Young Rae Ji; Jae-Young Kim; Jin Man Kim; Byung Hwa Hyun; Hwi Cheul Lee; Won Kyong Chang; Soo Bong Park; Do Hyung Kim; Hyun-Shik Lee; Yeon-Sik Choo; Sanggyu Lee; Zae Young Ryoo
Journal:  Transgenic Res       Date:  2011-01-09       Impact factor: 2.788

5.  Unequal meiotic crossover: a frequent cause of NF1 microdeletions.

Authors:  C López Correa; H Brems; C Lázaro; P Marynen; E Legius
Journal:  Am J Hum Genet       Date:  2000-04-20       Impact factor: 11.025

6.  An Interstitial 17q11.2 de novo Deletion Involving the CDK5R1 Gene in a High-Functioning Autistic Patient.

Authors:  Carla Lintas; Roberto Sacco; Claudio Tabolacci; Claudia Brogna; Marco Canali; Chiara Picinelli; Pasquale Tomaiuolo; Paola Castronovo; Marco Baccarin; Antonio M Persico
Journal:  Mol Syndromol       Date:  2018-08-01

7.  Type 2 NF1 deletions are highly unusual by virtue of the absence of nonallelic homologous recombination hotspots and an apparent preference for female mitotic recombination.

Authors:  Katharina Steinmann; David N Cooper; Lan Kluwe; Nadia A Chuzhanova; Cornelia Senger; Eduard Serra; Conxi Lazaro; Montserrat Gilaberte; Katharina Wimmer; Viktor-Felix Mautner; Hildegard Kehrer-Sawatzki
Journal:  Am J Hum Genet       Date:  2007-10-31       Impact factor: 11.025

8.  Copy number variations and cancer.

Authors:  Adam Shlien; David Malkin
Journal:  Genome Med       Date:  2009-06-16       Impact factor: 11.117

9.  Detection and characterization of NF1 microdeletions by custom high resolution array CGH.

Authors:  Eric Pasmant; Audrey Sabbagh; Julien Masliah-Planchon; Véronique Haddad; Marie-José Hamel; Ingrid Laurendeau; Jean Soulier; Béatrice Parfait; Pierre Wolkenstein; Ivan Bièche; Michel Vidaud; Dominique Vidaud
Journal:  J Mol Diagn       Date:  2009-09-18       Impact factor: 5.568

10.  Rapid development of optic glioma in a patient with hybrid phakomatosis: neurofibromatosis type 1 and tuberous sclerosis.

Authors:  Sami H Erbay; Stephen A Oljeski; Rafeeque Bhadelia
Journal:  AJNR Am J Neuroradiol       Date:  2004-01       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.